273 related articles for article (PubMed ID: 24670032)
1. Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway.
Pullarkat V; Meng Z; Tahara SM; Johnson CS; Kalra VK
Hemoglobin; 2014; 38(3):188-95. PubMed ID: 24670032
[TBL] [Abstract][Full Text] [Related]
2. MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease.
Li B; Zhu X; Ward CM; Starlard-Davenport A; Takezaki M; Berry A; Ward A; Wilder C; Neunert C; Kutlar A; Pace BS
Exp Hematol; 2019 Feb; 70():85-96.e5. PubMed ID: 30412705
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition induces a p38 MAPK pathway-dependent antiapoptotic program via Nrf2 in thyroid cancer cells.
Du ZX; Yan Y; Zhang HY; Liu BQ; Gao YY; Niu XF; Meng X; Wang HQ
J Clin Endocrinol Metab; 2011 May; 96(5):E763-71. PubMed ID: 21346076
[TBL] [Abstract][Full Text] [Related]
4. High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors.
Rushworth SA; Bowles KM; MacEwan DJ
Cancer Res; 2011 Mar; 71(5):1999-2009. PubMed ID: 21212410
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of NRF2 activation to mediate fetal hemoglobin induction and protection against oxidative stress in sickle cell disease.
Zhu X; Oseghale AR; Nicole LH; Li B; Pace BS
Exp Biol Med (Maywood); 2019 Feb; 244(2):171-182. PubMed ID: 30674214
[TBL] [Abstract][Full Text] [Related]
7. Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors.
Palani CD; Zhu X; Alagar M; Attucks OC; Pace BS
Blood Cells Mol Dis; 2024 Jan; 104():102792. PubMed ID: 37633023
[TBL] [Abstract][Full Text] [Related]
8. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection.
Dreger H; Westphal K; Weller A; Baumann G; Stangl V; Meiners S; Stangl K
Cardiovasc Res; 2009 Jul; 83(2):354-61. PubMed ID: 19351736
[TBL] [Abstract][Full Text] [Related]
9. The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome.
Vriend J; Reiter RJ
Mol Cell Endocrinol; 2015 Feb; 401():213-20. PubMed ID: 25528518
[TBL] [Abstract][Full Text] [Related]
10. Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress.
Pickering AM; Linder RA; Zhang H; Forman HJ; Davies KJA
J Biol Chem; 2012 Mar; 287(13):10021-10031. PubMed ID: 22308036
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram.
Lövborg H; Oberg F; Rickardson L; Gullbo J; Nygren P; Larsson R
Int J Cancer; 2006 Mar; 118(6):1577-80. PubMed ID: 16206267
[TBL] [Abstract][Full Text] [Related]
12. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).
Arlt A; Bauer I; Schafmayer C; Tepel J; Müerköster SS; Brosch M; Röder C; Kalthoff H; Hampe J; Moyer MP; Fölsch UR; Schäfer H
Oncogene; 2009 Nov; 28(45):3983-96. PubMed ID: 19734940
[TBL] [Abstract][Full Text] [Related]
13. Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia.
Khandros E; Thom CS; D'Souza J; Weiss MJ
Blood; 2012 May; 119(22):5265-75. PubMed ID: 22427201
[TBL] [Abstract][Full Text] [Related]
14. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
Krishnamoorthy S; Pace B; Gupta D; Sturtevant S; Li B; Makala L; Brittain J; Moore N; Vieira BF; Thullen T; Stone I; Li H; Hobbs WE; Light DR
JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046485
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
[TBL] [Abstract][Full Text] [Related]
16. RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice.
Kanzaki H; Shinohara F; Itohiya K; Yamaguchi Y; Katsumata Y; Matsuzawa M; Fukaya S; Miyamoto Y; Wada S; Nakamura Y
FASEB J; 2017 Feb; 31(2):781-792. PubMed ID: 27836987
[TBL] [Abstract][Full Text] [Related]
17. Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway.
Macari ER; Lowrey CH
Blood; 2011 Jun; 117(22):5987-97. PubMed ID: 21464371
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant effects of diallyl trisulfide on high glucose-induced apoptosis are mediated by the PI3K/Akt-dependent activation of Nrf2 in cardiomyocytes.
Tsai CY; Wang CC; Lai TY; Tsu HN; Wang CH; Liang HY; Kuo WW
Int J Cardiol; 2013 Sep; 168(2):1286-97. PubMed ID: 23453443
[TBL] [Abstract][Full Text] [Related]
20. Compensatory role of the Nrf2-ARE pathway against paraquat toxicity: Relevance of 26S proteasome activity.
Izumi Y; Yamamoto N; Matsushima S; Yamamoto T; Takada-Takatori Y; Akaike A; Kume T
J Pharmacol Sci; 2015 Nov; 129(3):150-9. PubMed ID: 26598004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
